Cytoreductive Surgery: Why, When, & How often?
The Carcinoid Cancer Foundation recently presented a Live Q&A session with Dr. Xavier Keutgen, discussing surgery for people living with neuroendocrine…READ MORE
March Luncheon with the Experts in New York City
Join neuroendocrine tumor (NET) patients in New York City on Sunday, March 10, 2019 for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues ranging…READ MORE
News about Neuroendocrine Cancer Expert Physicians
Three appointments and a newly established one-year neuroendocrine tumor (NET) fellowship herald an exciting new year for several NET specialists.
Edward M. Wolin, MD, Co-Medical Director of the Carcinoid Cancer Foundation, has been named Director…READ MORE
Seeking Participants for Carcinoid Syndrome and Carcinoid Tumor Focus Groups in July
Schlesinger Associates, a leading medical marketing research specialist, is seeking patients diagnosed with Carcinoid Syndrome and Carcinoid Tumors to participate in small focus group interviews on the topic of Carcinoid Syndrome and associated…READ MORE
Carcinoid NETs Health Storylines — Now Available in Seven Countries
The Carcinoid Cancer Foundation (CCF) and our partner Self Care Catalysts (SCC)…READ MORE
May Luncheon with the Experts in New York City for the Carcinoid and Neuroendocrine Tumor Community
Join carcinoid and neuroendocrine tumor patients in New York City on Sunday, May 21, 2017 for a unique opportunity to have lunch with three medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues…READ MORE
Gallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations (updated January 26, 2019)
The US Food and Drug Administration’s (FDA) June 1, 2016 approval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT® heralded a new age of nuclear imaging for neuroendocrine tumors in the United States.PLEASE SCROLL DOWN FOR A STATE-BY STATE LIST … READ MORE
Carcinoid Syndrome Impact Survey Results to Be Presented During September 21 Webcast
Members of the carcinoid and neuroendocrine tumor community are invited to be the first to hear the results of the Carcinoid Syndrome Impact Survey that was conducted this summer. A Webcast about the survey results will be presented on Wednesday, September…READ MORE
Show Your Stripes by Contributing to Carcinoid and NET Research
Don’t miss this opportunity to Show Your Stripes by participating in the first ever Project Zebra: Real-World Patient Journey Research for Carcinoid and Neuroendocrine Tumors in the United States.
The Carcinoid Cancer Foundation…READ MORE
Los Angeles Neuroendocrine Tumor Patient Education Conference 2016
Join neuroendocrine tumor (NET) patients and family members, NET cancer expert physicians, and members of the healthcare community on Saturday, June 25, 2016 for a free, one-day conference at Cedars-Sinai Medical Center in Los Angeles. The conference…READ MORE